Scientists Often ‘Conveniently’ Withhold Negative Drug Trial Information
January 11, 2012
By Anthony Gucciardi
“More evidence that drug companies are not telling you the truth about their products that are supposed to be safe and effective.” –KTRN
It has been revealed that scientists conducting clinical trials for pharmaceuticals and many other medical interventions oftentimes withhold vital data that may be threatening public health.
In a review published in the British Medical Journal (BMJ), it was found that scientists frequently engage in fraudulent data withholding — the act of keeping inconvenient and unwanted evidence out of the end result.
The findings bring into question the validity of nearly all clinical drug trials, as previous reports have highlighted the hidden dangers of many common pharmaceutical medications. Tylenol, one of the most popular over-the-counter drugs for a number of common ailments has been the subject of one such study.
It was found that low doses of Tylenol can actually be even more deadly than massive overdose, leading to a number of preventable deaths and hospitalizations each year from consumers taking Tylenol to help overcome mild symptoms.
A History of Hidden Pharmaceutical Dangers
Another pharmaceutical drug recently under the spotlight is Aspirin. Shockingly, aspirin may be to blame for intestinal injuries and internal bleeding, according to recent peer-reviewed research. Perhaps the most shocking relationship of all, however, is the link between antibiotics and a host of diseases. Found to cause obesity, metabolic syndrome, mental illness, and gut imbalance, antibiotics actually deplete the beneficial bacteria in your gut known as probiotics and wreak havoc on your immune system.